Abstract
Sexual/vulvovaginal health concerns are prevalent in breast cancer survivors. Limited data exists regarding vulvovaginal health changes and sexual health concerns associated with specific endocrine therapy (ET) treatments and duration of use. More research is needed to facilitate early intervention and symptom management.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
